Plasma levels of vascular endothelial growth factor (VEGF) are predictive of disease-progression in B-cell chronic lymphocytic leukemia (B-CLL).

被引：0
|
作者：
Maurillo, L [1 ]
Del Poeta, G [1 ]
Venditti, A [1 ]
Giovanna, S [1 ]
Buccisano, F [1 ]
Del Principe, MI [1 ]
Tamburini, A [1 ]
Scornajenghi, A [1 ]
Epiceno, AM [1 ]
Piccioni, D [1 ]
Amadori, S [1 ]
机构：
[1] Univ Roma Tor Vergata, I-00173 Rome, Italy
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1517
引用
收藏
页码：360A / 360A
页数：1
相关论文
共 50 条
  • [21] SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AS PROGNOSTIC PARAMETER IN UNTREATED PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    Antic, D.
    Cokic, V.
    Fekete, M. Dencic
    Jovanovic, M. Perunicic
    Evic, V. Milo
    Kurtovic, N. Kraguljac
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 524 - 524
  • [22] All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
    Bairey, O
    Boycov, O
    Kaganovsky, E
    Zimra, Y
    Shaklai, M
    Rabizadeh, E
    LEUKEMIA RESEARCH, 2004, 28 (03) : 243 - 248
  • [23] Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia
    Smolej, Lukas
    Andrys, Ctirad
    Pekova, Sona
    Schwarz, Jiri
    Belada, David
    Zak, Pavel
    HAEMATOLOGICA, 2006, 91 (10) : 1432 - 1433
  • [24] Spontaneous apoptosis and proliferation predict disease progression within ZAP-70 negative B-cell chronic lymphocytic leukemia (B-CLL)
    Del Poeta, G
    Del Principe, MI
    Niscola, P
    Maurillo, L
    Venditti, A
    Buccisano, F
    Consalvo, MI
    Mazzone, C
    Panetta, P
    Degan, M
    Pasqua, I
    Bruno, A
    Gattei, V
    Lo Coco, F
    Amadori, S
    BLOOD, 2005, 106 (11) : 349A - 349A
  • [25] Clinical significance of CD69 expression in B-cell Chronic Lymphocytic Leukemia (B-CLL)
    Del Poeta, G.
    Del Principe, M., I
    Luciano, F.
    Maurillo, L.
    Buccisano, F.
    Gattei, V
    Niscola, P.
    Venditti, A.
    Imo Consalvo, M.
    Catalano, G.
    de Fabritiis, P.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 108
  • [26] A CASE OF CLASSICAL KAPOSIS-SARCOMA IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    CONTU, L
    CARCASSI, C
    LANASA, G
    ZURRIDA, SM
    SIRIGU, F
    DELGIACCO, S
    CERIMELE, D
    LONGINOTTI, M
    PITZUS, F
    TUMORI, 1986, 72 (04) : 365 - 374
  • [27] Prognostic relevance of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL)
    D'Arena, G.
    Napolitano, M.
    Marcacci, G.
    Russo, F.
    Vigliotti, M. L.
    Mauro, F.
    Corazzelli, G.
    Frigeri, F.
    Della Cioppa, P.
    Svanera, G.
    Capobianco, G.
    Nasuti, A.
    Villani, O.
    Pinto, A.
    CYTOMETRY PART A, 2006, 69A (05) : 449 - 449
  • [28] Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
    Robak, T
    Blonski, JZ
    Kasznicki, M
    Gora-Tybor, J
    Konopka, L
    Dmoszynska, A
    Skotnicki, AB
    Stella-Holowiecka, B
    Kuliczkowski, K
    Dwilewicz-Trojaczek, J
    BLOOD, 2000, 96 (11) : 293B - 293B
  • [29] Consolidation with rituximab improves outcome in high risk B-cell chronic lymphocytic leukemia (B-CLL)
    Del, Poeta G.
    Del, Principe M., I
    Maurillo, L.
    Buccisano, F.
    Niscola, F.
    Catalano, G.
    Venditti, A.
    Gattei, V
    Perrotti, A. P.
    de Fabritiis, F.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 23 - 23
  • [30] Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia
    Molica, S
    Vitelli, G
    Levato, D
    Gandolfo, GM
    Liso, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (03) : 605 - 610
12345